Cilvoryl MV 2mg/500mg/0.2mg Tablet SR
Marketer
Vasu Organics Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Cilvoryl MV 2mg/500mg/0.2mg Tablet SR
Diabeva Triple Action 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabeva Triple Action should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (sugary foods or juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Cilvoryl MV 2mg/500mg/0.2mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cilvoryl MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Cilvoryl MV 2mg/500mg/0.2mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cilvoryl MV 2mg/500mg/0.2mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Cilvoryl MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Cilvoryl MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Cilvoryl MV 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Cilvoryl MV 2mg/500mg/0.2mg Tablet SR works:
Cilvoryl MV SR tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cilvoryl MV 2mg/500mg/0.2mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Cilvoryl MV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice from your doctor.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Cilvoryl MV 2mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Cilvoryl MV 2mg/500mg/0.2mg SR tablets in individuals with kidney impairment poses a likely risk and should be disregarded. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Cilvoryl MV 2mg/500mg/0.2mg SR tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease typically begin with a reduced Cilvoryl MV 2mg/500mg/0.2mg SR tablet dosage; however, its use is contraindicated in those with severe hepatic dysfunction. Medical advice is recommended.
What if you forget to take Cilvoryl MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Cilvoryl MV 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Cilvoryl MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently